Fay
Fay is a telehealth company offering personalized nutrition counseling from registered dietitians, with services often covered by insurance.
Secondary Market Price
How Fay Measures Up
To help you manage your Fay equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series B
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Fay's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Fay Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Fay's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Fay Nutrition is a software development company that operates a preventative care platform integrating food, movement, sleep, and stress reduction. The company provides board-certified registered dietitians (RDs) with a B2B2C software solution, described as a 'business in a box,' while engaging clients through AI-driven reward systems, tracking, and insights. Fay also works with health insurance companies, employers, and government agencies to identify cost-saving opportunities. Founded in 2017, the company has since raised $75 million in funding from investors such as General Catalyst, Forerunner, and Goldman Sachs, and now serves thousands of users across the United States.
Looking forward, Fay is focused on scaling its platform to expand access to preventative care. The company's growth is supported by a $50 million Series B funding round in March 2025, which will aid in the continued development of its AI-driven ecosystem and partnerships. Recent announcements include a partnership with New York Sports Club (NYSC) to integrate nutrition and fitness for members, an integration with Withings connected devices to link health data with dietitian advice, and a collaboration with the National Alliance for Eating Disorders to provide specialized care. Fay also became Amazon’s first nutrition partner and was recognized on the CB Insights Digital Health 50 list for its AI-driven approach to healthcare.
- Goldman Sachs
- General Catalyst
- Forerunner Ventures
- 1984 Ventures
- Co-Founder, Sammy Faycurry
- Co-Founder, Mark Stefanski
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Fay worth joining?
Deciding whether to join Fay depends on your career goals and your assessment of the company's long-term potential. Tools like Prospect can help you evaluate the potential value of your equity compensation to make a more informed decision.
What should I do with my Fay stock?
The right strategy for your Fay stock depends on your personal financial goals, tax situation, and risk tolerance. Platforms like Prospect can build a personalized plan to help you optimize option exercises and sales to maximize your after-tax value.
Can you sell Fay stock?
As Fay is a private company, you can typically sell stock through secondary markets or during company-approved tender offers, though it is more complex than selling public shares. Resources like Prospect offer tools and strategies to help you navigate selling private shares at tax-optimal times.
How can I find the value of my Fay stock?
The value of private stock is often determined by the company's latest 409A valuation or the price set in a recent funding round. For a more dynamic valuation, Prospect uses predictive models trained on VC data to help you forecast your equity's future value.
What is Fay's equity worth?
The total worth of your Fay equity depends on the company's future success and your strategy for managing taxes and exercising options. To understand its potential net value, you can use platforms like Prospect, which model different scenarios to help you maximize your returns.
What is Fay's stock ticker symbol?
As a private, pre-IPO company, Fay does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Fay stock?
Selling private Fay stock is sometimes possible through secondary markets, while buying is generally restricted to accredited investors during specific funding rounds. For employees who already hold equity, platforms like Prospect provide tools to manage and optimize the value of those shares.
What is the criteria to buy or invest in Fay stock?
Investing directly in a private company like Fay is typically limited to venture capital firms and accredited investors who meet specific financial thresholds. For employees who receive equity as compensation, tools like Prospect are designed to help manage that stake, not facilitate new investments.
